Studies have shown that combined HRT (estrogen and progesterone) can increase the risk of breast cancer. The risk appears to rise with longer durations of use and decreases after stopping the therapy. Estrogen-only HRT, primarily used in women who have had a hysterectomy, carries a lower risk of breast cancer compared to combined HRT.
